Background: The importance of bone regeneration after enucleation of the mandibular odontogenic cyst is emphasized. There are many different regenerative materials investigated, such as collagen membranes and platelet-rich fibrin (PRF), which has not yet been established as more effective. Objective: To compare collagen membrane and PRF for bone regeneration following surgical enucleation of mandibular odontogenic cysts. Methods: The study was a comparative clinical study carried out at Rehman Medical Institute, Peshawar, from November 2025 to April 2026, involving a total of 56 patients. Patients were divided equally into collagen membrane and PRF groups (n=28 each). The radiographic assessment of bone regeneration, postoperative healing, and complications was followed for 8 weeks. Data were analyzed using SPSS version 26; p<0.05 was considered statistically significant. Results: Mean defect area reduction was 36.5 ± 11.0% in the collagen group and 40.3 ± 12.0% in the PRF group (p=0.222). These were 37 ± 15 and 44 ± 17 arbitrary units, respectively (p=0.109). Complete mucosal healing occurred in 78.6% and 89.3% of patients, respectively. Complication rates were 17.9% and 10.7%, respectively (p=0.445). Between-group differences were not statistically significant. Conclusion: Both materials showed favourable short-term healing outcomes, without evidence of superiority. Larger and longer follow-up randomized studies are needed.
Odontogenic cysts are one of the most commonly seen pathological lesions in the jaws, and they form in the remnants of the epithelial elements involved in the formation of a tooth and odontogenesis.[1] Among these cysts, some are important, such as radicular cysts, dentigerous cysts, and odontogenic keratocysts, which have different biological behaviour and potential for bone destruction.[2] While the majority of odontogenic cysts are non-cancerous, their continuous growth can cause a significant amount of bone destruction, cortical bone thinning, tooth displacement, and loss of integrity of the mandible.[3] Surgical enucleation is still a very common treatment modality; however, in larger lesions where spontaneous bone regeneration is less reliable, healing may take a long time.[4] Therefore, achieving adequate bone regeneration after the removal of the cyst is crucial in oral and maxillofacial surgery and has several implications, such as functionality, preservation of anatomical structures, and further dental rehabilitation.[5] Guided bone regeneration (GBR) is a promising therapy for the treatment of osseous defects that enables selective migration of osteogenic cells and prevents the invasion of rapidly proliferating soft tissues.[6] The main reason for the use of resorbable collagen membranes in GBR is their biocompatibility, biodegradability, and ability to offer a provisional barrier to promote bone formation.[7] They are structurally conducive to wound stabilization and a favorable environment for osteogenesis.[7] However, there are some challenges that may limit the use of collagen membranes, such as material costs, degradation rate variability, and decreased mechanical support for larger defects. Subhadarsanee et al. (2023) conducted a randomized clinical trial using 24 patients with Class II furcation defects and compared the clinical and radiographic results of collagen and platelet-rich fibrin matrix membranes with bone grafting; clinical and radiographic outcomes were improved in both groups.[8] The results of this study further substantiate the clinical significance of the membrane-based regenerative modalities, but should not be extrapolated to the outcomes in periodontal defects or postoperative odontogenic cyst cavities.
The platelet-rich fibrin (PRF) is an autologous second-generation platelet concentrate that has been gaining traction in regenerative dentistry due to its biological activity, ease of preparation, and promise for improving the tissue repair process.[9] It is a three-dimensional fibrin network with platelets, leukocytes, and growth factors that play a role in the process of angiogenesis, cell proliferation, and tissue repair.[10] As a blood-derived product, PRF is a naturally active membrane, free from routine use of anticoagulants, and can be a potentially cost-effective alternative to commercially manufactured collagen membranes.[11] In a randomized controlled trial involving 36 patients undergoing secondary alveolar cleft grafting, Eid et al. (2024) investigated PRF and collagen membranes as adjuncts to autogenous bone grafting, demonstrating the clinical applicability of both materials in maxillofacial bone reconstruction.[12] Additionally, a 2026 randomized study of 40 patients with alveolar defects showed significant bone regeneration in both PRF and Collagen groups, with slightly more horizontal regeneration in the collagen group and no difference in complications or vertical regeneration.[13]
In clinical environments where treatment cost and availability of sophisticated biomaterials can impact treatment decisions, the biological advantages and low cost of an effective regenerative material are additional considerations. While collagen membranes have proven to be a barrier-based solution, PRF can offer the benefits of autologous preparation, growth factor delivery, and enhanced tissue healing. Comparable properties of these materials in mandibular odontogenic cyst defects, therefore, could give clinically meaningful information about their relative regenerative potential and guide the choice of adequate postoperative treatment approaches.
The present study was designed to compare the success of collagen membrane and platelet-rich fibrin in the promotion of bone regeneration after surgical enucleation of mandibular odontogenic cysts, focusing on postoperative radiographic bone formation and healing success.
A comparative clinical study was conducted in the Department of Oral and Maxillofacial Surgery of Rehman Medical Institute, Peshawar, Pakistan. The study period lasted for six months, from 1st November 2025 until 30th April 2026. This time frame included patient recruitment, surgical procedures, post-surgical evaluation, and data collection.
Patient recruitment was by non-probability consecutive sampling. All patients who were found to have a mandibular odontogenic cyst during the period of the study were evaluated according to the predetermined inclusion criteria. Patients with eligibility criteria and informed consent signed were enrolled consecutively until the number of patients was reached. The patients were divided into two groups: Group A was given a resorbable collagen membrane, while Group B was given platelet-rich fibrin after cyst enucleation. Patients aged 18-60 years of age, regardless of gender, with a clinically and radiographically diagnosed mandibular odontogenic cyst that needed surgical enucleation were eligible. Patients who had cystic defects with a maximum diameter between 1 and 5 cm on the radiographs, good general health, and readiness to attend the planned postoperative follow-up were included. Patients with lesions that were later diagnosed from histopathology as odontogenic cysts were kept in the final analysis. Patients who had uncontrolled diabetes mellitus, immunodeficiency or metabolic bone disease, or other systemic illnesses known to affect bone healing were excluded. Other exclusion criteria included patients on corticosteroids, immunosuppressive therapy, anticoagulants, or drugs that affect bone metabolism. Other exclusion criteria were: previous radiotherapy to the maxillofacial area, recurrent lesions of the cysts, pathological fracture of the mandibles, active osteomyelitis, platelet disease, thrombocytopenia, and contraindications for venepuncture. There were no additional bone grafting operations or any lesions subsequently found to be odontogenic tumours or other non-cystic lesions to reduce the possibility of confounding.
A sample size calculation was performed for comparing two independent means with the use of the sample size calculator for comparing two independent means (OpenEpi version 3.01). A previous randomized controlled clinical trial published in BMC Oral Health (2025) involved 20 patients and was split into 10 patients in the treatment group and 10 in the control group. Bone regeneration after surgery was assessed in this study, and a helpful methodological reference was presented for the current study.[14] A 95% confidence level, 80% statistical power, 1:1 allocation ratio, and an assumed standardized effect size of 0.80 were assumed for the proposed sample size estimation. The minimum sample size estimated was 25 participants per group using the normal approximation for comparing two independent means. The proposed sample size was raised to 56 patients, 28 in each group, after accounting for approximately 10% for potential loss to follow-up. After institutional ethical approval, patients with suspected mandibular odontogenic cysts were evaluated based on detailed medical and dental histories, clinical examination, and radiographic investigations. After institutional ethical approval, patients with suspected mandibular odontogenic cyst was assessed based on detailed medical and dental histories, clinical examination and radiographic investigations. A structured data collection proforma was used to record the relevant demographic details, including age, gender, presenting symptoms, cyst location, and lesion size. Panoramic radiography was used with CBCT if indicated in order to evaluate lesion size, involvement of the cortical bone, and the proximity of the lesion to neighboring anatomic structures. Prior to obtaining informed consent, all participants were subject to routine, pre-operative evaluation, and were informed about the surgical procedure, potential complications, and post-operative follow-up needs.
All surgeries were conducted under proper anaesthesia and were done with a standardized approach, and enucleation was performed. After elevation of the mucoperiosteum and adequate exposure of the cystic cavity, the cyst lining was carefully removed, and the surgical site was irrigated with sterile normal saline. The excised tissue was submitted to histopathology for confirmation of the diagnosis. In Group A, a sterile resorbable collagen membrane was adapted to the bony defect following the manufacturer's instructions in order to create a barrier between the osseous cavity and the surrounding soft tissues. In Group B, the venous blood was collected from patients and processed to obtain autologous PRF using a standard centrifugation protocol and then introduced into the remaining bony cavity. No additional bone graft material was used in either group. The surgical flap was then relocated and stitched in place to ensure a good closure of the wound. The postoperative instructions, pain relief, and oral hygiene advice were the same for both groups.
The wound healing, postoperative pain, postoperative swelling, postoperative infection, wound dehiscence, and other complications were evaluated using the postoperative assessment at the determined follow-up visits. A radiographic evaluation was carried out using a standard protocol for the imaging of the site to evaluate bone regeneration within the operated site. The main endpoint was the difference between the immediate postoperative X-ray bone density and the X-ray bone density at the follow-up visit. Secondary outcomes comprised a decrease in the dimensions of residual defects and the incidence of postoperative complications. All the measurements were made on the radiograph with the same anatomical references and imaging parameters, comparing the collagen membrane with the PRF groups. All of the information collected was recorded on the study proforma and double-checked for completeness prior to statistical analysis. The data were analyzed with IBM SPSS Statistics 26.0 software. All quantitative variables such as age, cyst dimension, radiographic bone density, and defect size changes were presented as mean and standard deviation for variables with normal distribution and median and interquartile range for variables with non-normal distribution. Qualitative data such as age, sex, type of cyst, anatomical location, and complications after surgery were reported as frequencies and percentages. The Shapiro–Wilk test was used to assess the normality of continuous variables. An independent-samples t-test was employed to compare the continuous normally distributed data between the collagen membrane group and PRF group. The chi-square test and Fisher's exact test were used to compare categorical variables. For the comparison of follow-up bone density after adjusting for baseline differences, the analysis of covariance was used when baseline differences existed. A p-value < 0.05 on both sides of the tail was deemed statistically significant, and 95% confidence intervals were provided for key between-group comparisons.
A total of 56 patients were included in the analysis, with 28 patients each in the collagen membrane and platelet-rich fibrin (PRF) groups. The mean age was 34.8 ± 10.2 years in the collagen group and 35.6 ± 11.0 years in the PRF group. There was a slight male predominance in both groups. The most prevalent presenting symptom was swelling, and pain was the second most prevalent. There were no statistically significant differences (p > 0.05) between these two groups in the baseline demographic and clinical parameters (Table 1).
|
Variable |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Age (years), mean ± SD |
34.8 ± 10.2 |
35.6 ± 11.0 |
0.779 |
|
Age 18–30, n (%) |
11 (39.3) |
10 (35.7) |
0.783 |
|
Age 31–45, n (%) |
12 (42.9) |
12 (42.9) |
— |
|
Age 46–60, n (%) |
5 (17.9) |
6 (21.4) |
— |
|
Male, n (%) |
15 (53.6) |
16 (57.1) |
0.789 |
|
Female, n (%) |
13 (46.4) |
12 (42.9) |
— |
|
Pain at presentation, n (%) |
18 (64.3) |
17 (60.7) |
0.783 |
|
Swelling at presentation, n (%) |
21 (75.0) |
20 (71.4) |
0.763 |
|
Incidental finding, n (%) |
5 (17.9) |
6 (21.4) |
0.738 |
The most common lesions were radicular cysts, dentigerous cysts, and odontogenic keratocysts. The majority of lesions were in the posterior mandible. The mean maximum cyst size was 3.12 ± 0.83 cm for collagen and 3.08 ± 0.79 cm for PRF. There were no statistically significant between-group differences for baseline defect dimensions, cortical thinning, and tooth displacement (p>0.05) (Table 2).
|
Variable |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Radicular cyst, n (%) |
15 (53.6) |
14 (50.0) |
0.962 |
|
Dentigerous cyst, n (%) |
9 (32.1) |
10 (35.7) |
— |
|
Odontogenic keratocyst, n (%) |
4 (14.3) |
4 (14.3) |
— |
|
Posterior mandible, n (%) |
19 (67.9) |
18 (64.3) |
0.777 |
|
Anterior mandible, n (%) |
9 (32.1) |
10 (35.7) |
— |
|
Maximum diameter (cm), mean ± SD |
3.12 ± 0.83 |
3.08 ± 0.79 |
0.854 |
|
Baseline defect area (cm²), mean ± SD |
7.4 ± 2.2 |
7.2 ± 2.1 |
0.729 |
|
Cortical thinning, n (%) |
17 (60.7) |
16 (57.1) |
0.786 |
|
Tooth displacement, n (%) |
7 (25.0) |
6 (21.4) |
0.752 |
There was no significant difference in the mean operative duration between the two groups, with the collagen group taking 48.6 ± 10.4 minutes and the PRF group 44.2 ± 9.8 minutes (p = 0.109). In most cases, local anaesthetic was used, and in both groups, 96.4% of patients had complete primary wound closure. Histopathological examination confirmed odontogenic cysts in all cases (Table 3).
|
Variable |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Operation time (min), mean ± SD |
48.6 ± 10.4 |
44.2 ± 9.8 |
0.109 |
|
Local anaesthesia, n (%) |
23 (82.1) |
24 (85.7) |
0.716 |
|
General anaesthesia, n (%) |
5 (17.9) |
4 (14.3) |
— |
|
Intraoperative cortical perforation, n (%) |
4 (14.3) |
3 (10.7) |
0.686 |
|
Additional bone graft used, n (%) |
0 (0.0) |
0 (0.0) |
Not tested |
|
Complete primary closure, n (%) |
27 (96.4) |
27 (96.4) |
1.000 |
|
Histopathology confirmed cyst, n (%) |
28 (100) |
28 (100) |
Not tested |
After 8 weeks, both groups showed a decrease in residual defect area along with an increase in radiographic grayscale index. The collagen group had a mean defect area reduction of 36.5± 11.0% vs. the PRF group, which had a mean defect area reduction of 40.3±12.0% (p = 0.222). The difference in grayscale index was also higher in the PRF group compared to the non-PRF group (44±17 vs 37±15 arbitrary units, respectively), although this was not statistically significant (p = 0.109) (Table 4).
|
Outcome |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Baseline defect area (cm²), mean ± SD |
7.4 ± 2.2 |
7.2 ± 2.1 |
0.729 |
|
8-week defect area (cm²), mean ± SD |
4.7 ± 1.8 |
4.3 ± 1.7 |
0.396 |
|
Absolute area reduction (cm²), mean ± SD |
2.7 ± 1.1 |
2.9 ± 1.2 |
0.518 |
|
Defect area reduction (%), mean ± SD |
36.5 ± 11.0 |
40.3 ± 12.0 |
0.222 |
|
Baseline grayscale index (arbitrary units) |
82 ± 17 |
81 ± 18 |
0.831 |
|
8-week grayscale index (arbitrary units) |
119 ± 22 |
125 ± 23 |
0.322 |
|
Grayscale index change, mean ± SD |
37 ± 15 |
44 ± 17 |
0.109 |
The healing outcome after surgery was also favourable in the PRF group, numerically. The mean pain scores on postoperative day seven were 1.9 ± 1.0 in the PRF group and 2.4 ± 1.1 in the collagen group (p = 0.081). At two weeks, the rate of complete mucosal healing was 89.3% and 78.6%, respectively. The other differences in pain, swelling, mucosal healing, and wound dehiscence did not reach statistical significance (p > 0.05) (Table 5).
|
Outcome |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Pain VAS, day 1, mean ± SD |
5.1 ± 1.4 |
4.8 ± 1.5 |
0.442 |
|
Pain VAS, day 7, mean ± SD |
2.4 ± 1.1 |
1.9 ± 1.0 |
0.081 |
|
Swelling on day 7, n (%) |
9 (32.1) |
6 (21.4) |
0.365 |
|
Complete mucosal healing, week 2, n (%) |
22 (78.6) |
25 (89.3) |
0.275 |
|
Complete mucosal healing, week 4, n (%) |
27 (96.4) |
28 (100) |
0.313 |
|
Wound dehiscence by week 2, n (%) |
3 (10.7) |
1 (3.6) |
0.299 |
No significant differences were detected between the overall postoperative complication rates of the collagen group (17.9%) and the PRF group (10.7%) (p = 0.445). The PRF group had a lower incidence of postoperative infection, persistent pain, and secondary procedure, while there was no difference between the groups for transient neurosensory disturbance. All patients completed the eight-week radiographic follow-up, with no reported losses to follow-up (Table 6).
|
Outcome |
Collagen (n=28) |
PRF (n=28) |
p-value |
|
Postoperative infection, n (%) |
2 (7.1) |
1 (3.6) |
0.553 |
|
Persistent pain at week 4, n (%) |
2 (7.1) |
1 (3.6) |
0.553 |
|
Transient neurosensory disturbance, n (%) |
1 (3.6) |
1 (3.6) |
1.000 |
|
Secondary intervention, n (%) |
1 (3.6) |
0 (0.0) |
0.313 |
|
Any complication, n (%) |
5 (17.9) |
3 (10.7) |
0.445 |
|
Completed 8-week imaging, n (%) |
28 (100) |
28 (100) |
|
|
Lost to follow-up, n (%) |
0 (0.0) |
0 (0.0) |
|
The present study showed bone regeneration after enucleation of mandibular odontogenic cyst in both the collagen membrane and platelet-rich fibrin (PRF) groups. PRF numerically reduced the area of the defects (40.3% decrease in area compared to 36.5%) and improved the radiographic grayscale index (44 arbitrary units versus 37). However, these changes were not statistically significant. This result was aligned with Shokry et al. (2025), who compared the bone cavity reduction and improvement of bone density in 20 patients following jaw cyst enucleation, and concluded that there was no significant difference between the two groups, albumin-PRF and conventional healing.[14] In another study, Kompalli et al. (2026) found similar bone regeneration in 40 patients with alveolar defects, in which both groups were given PRF and collagen membranes for the alveolar defects.[15]
The results also corroborated those of Eid et al. (2024), who studied PRF and collagen membranes for use in secondary alveolar cleft reconstruction, a finding that confirmed the use of both materials in bone regeneration in the clinical setting.[12] Subhadarsanee et al. (2023) conducted a randomized trial with 24 patients having mandibular furcation defects and found that the PRF matrix and collagen membranes resulted in improved clinical outcomes; however, some parameters favoured the PRF matrix[8]. Likewise, Bhagat et al. (2025) observed improvements in clinical and radiographic parameters with both advanced PRF and collagen membranes in infrabony defects, without a significant difference in clinical attachment gain.[16] These studies were, however, done with different defects and grafting techniques, so comparisons are limited.
In contrast, PRF has been reported by Li et al. (2023) to induce significantly higher bone formation after jaw cyst surgery when it was used in combination with an artificial bone material (92.87%) versus the use of only cystectomy (76.06%).[17] Likewise, Banik et al. (2022) found that platelet-rich plasma was a successful treatment for early radiographic bone regeneration following the removal of a jaw cyst.[18] These results indicated possible benefits from platelet concentrates, but the use of other grafting materials in the former study and platelet-rich plasma (PRP) in the latter study prevented the findings from being solely attributed to PRF.[18]
When it came to postoperative recovery, there were slightly lower pain scores, a higher complete mucosal healing rate, and fewer complications in the PRF group, but neither of these differences was statistically significant. The results of Karkle et al. (2025) were also negative, with no clear benefit of advanced PRF added to the benefit of endodontic microsurgery in terms of radiography.[19] Although favourable soft-tissue healing observations were reported, no clear additional radiologic benefit of advanced PRF was found. You et al. (2023) also examined PRF and growth factors in early healing after endodontic microsurgery, further demonstrating the importance of volumetric assessment to assess regenerative interventions.[20] These studies led to prudent interpretation of the trends observed in the healing process, especially in view of the possibility that defect size and surgical technique can affect the healing process.
In addition, Ribeiro et al. (2024) conducted a systematic review of platelet- and leukocyte-rich fibrin in oral and maxillofacial surgery, which indicated beneficial effects on wound healing and bone repair, and highlighted the necessity for further clinical studies.[21] Taken together, the literature pointed towards both collagen membranes and PRF being capable of supporting regenerative treatment; however, the effectiveness of the two products was dependent upon the clinical situation. The results of the present study indicated similar short-term results, but they did not prove one material to be superior to the other.
The results must be viewed with caution due to the limited sample size, the short eight-week follow-up, and cyst size and healing effects. Moreover, the radiographic measurements of gray scales were not comparable with the standardized bone mineral density measures. There would be a need for larger randomized clinical trials with standardized CBCT evaluation and extended follow-up times to establish which of the two regeneration procedures offers a clinically significant benefit.
LIMITATIONS
There were some limitations to this study. The findings were limited in their generalizability due to the relatively small sample size and single-center design. The eight-week follow-up was not long enough to assess for full bone maturation and for long-term success of regeneration. Postoperative healing may have been affected by variations in cyst size, location, and morphology. Also, the radiographic grayscale measurement did not give a standardized measurement of bone mineral density, but rather an indirect measure of bone regeneration. This was also the case due to the non-randomized sampling and the lack of a conventional healing control group.
Both collagen membrane and platelet-rich fibrin demonstrated favourable short-term bone regeneration following surgical enucleation of mandibular odontogenic cysts. PRF demonstrated statistically non-significant but higher rates of bone formation, mucosal healing, and fewer postoperative complications, although these were expressed numerically. There was no obvious advantage in one material over the other. Larger randomized controlled trials with longer follow-up are recommended to confirm their relative efficacy.